Search Results - "Elajez, Reem"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar by Abushanab, Dina, Atchan, Mounir, Elajez, Reem, Elshafei, Mohamed, Abdelbari, Ahmed, Al Hail, Moza, Abdulrouf, Palli Valapila, El-Kassem, Wessam, Ademi, Zanfina, Fadul, Abdalla, Abdalla, Elmustafa, Diab, Mohammad Issam, Al-Badriyeh, Daoud

    Published in PloS one (01-06-2023)
    “…With an increasingly strained health system budgets, healthcare services need to continually demonstrate evidence of economic benefits. This study sought to…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Safety evaluation of intravenous immunoglobulin in pediatric patients: a retrospective, 1-year observational study by Elajez, Reem, Ezzeldin, Asmaa, Gaber, Hossamaldein

    “…Intravenous immunoglobulin (IVIG) is a pooled human plasma protein that has shown efficacy in treating a variety of disorders. IVIG is generally well tolerated…”
    Get full text
    Journal Article
  4. 4

    Efficacy and safety of intravenous fosfomycin for the treatment of difficult-to-treat Gram-negative bacterial infections by Abdallah, Tasneem A.K., Elajez, Reem, Ibrahim, Tawheeda B., Alimam, Abeir B., Omrani, Ali S.

    Published in Journal of infection and public health (01-11-2021)
    “…We reviewed the efficacy and safety of intravenous (IV) fosfomycin for the treatment of infections caused by Gram-negative bacteria (GNB) with…”
    Get full text
    Journal Article
  5. 5

    Knowledge, Attitudes, and Awareness of Food and Drug Interactions (FDI) Among Nurses on General Medical Wards: A Cross-Sectional Study by Elajez, Reem, Alkhawaja, Raja, Kehyayan, Vahe, Shukaili, Khadija Al, Swallmeh, Esmat

    Published in SAGE open nursing (01-01-2024)
    “…Food and nutritional supplements can interact with medication and cause drug interaction. Registered nurses play an essential role in patients' safety related…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Myelosuppression Effect Of Trimethoprim-Sulfamethoxazole Prophylaxis In Innate Immune Defect Patients: Retrospective Comparative Study by Elajez, Reem, Adeli, Mehdi

    Published in Journal of allergy and clinical immunology (01-02-2018)
    “…Rationale To indicate and report the frequency of myelosuppression effect seen with prophylactic dose of Trimethoprim-Sulfamethoxazole (TMP-SMX) in two groups:…”
    Get full text
    Journal Article
  8. 8

    Management of anaphylaxis in children: a survey of parents and school personnel in Qatar by Mohammed Elhassan, Shaza, Charlson, Mary, Jama, Hibaq, Zakri, Farhan, Elajez, Reem Hassan, Ahmed, Fayeha, Taheri, Shahrad

    Published in BMJ paediatrics open (01-10-2017)
    “…BackgroundAllergies are a growing health concern with a significant impact on quality of life and healthcare costs. It is critical to develop an appropriate…”
    Get full text
    Journal Article
  9. 9

    Trimethoprim–Sulfamethoxazole: new lessons on an old antimicrobial; a retrospective analysis by Bakdach, Dana, Elajez, Reem

    “…Objective This study aimed to evaluate the appropriateness of TMP‐SMX prescriptions as part of drug utilization review. Method Charts of all patients (adults…”
    Get full text
    Journal Article
  10. 10

    Does Trimethoprim-Sulfamethoxazole prophylaxis induce myelosuppression in primary immune deficiency disease patients; A retrospective, 3 groups comparative study by Elajez, Reem, Nisar, Sabha, Adeli, Mehdi

    “…The possible myelosuppression side effect of Trimethoprim-Sulfamethoxazole (TMP-SMX) on primary immune deficiency (PID) patients has not been established yet…”
    Get more information
    Journal Article
  11. 11

    Thrombocytopenia Associated With Teicoplanin Use: A Retrospective Observational Study by Elajez, Reem, Abdallah, Ibtihal, Bakdach, Dana, Shaat, Eman, Osman, Enas, Baraka, Mona, Gergess, Rania, Abdalla, Rehab, Al Hamoud, Eman, Al Bakri, Muna, Al Soub, Hussam

    Published in The Annals of pharmacotherapy (01-11-2022)
    “…Background: Contradictory studies reporting vast heterogeneity in the teicoplanin-induced thrombocytopenia (TIT) incidence exist. Objective: To identify the…”
    Get full text
    Journal Article
  12. 12

    Hospital pharmacists’ self-evaluation of their competence and confidence in conducting pharmacy practice research by Awaisu, Ahmed, Bakdach, Dana, Elajez, Reem Hasan, Zaidan, Manal

    Published in Saudi pharmaceutical journal (01-07-2015)
    “…Objectives: Research is essential to the advancement of pharmacy practice and healthcare. Pharmacists have a pivotal role to play in this strategy. However,…”
    Get full text
    Journal Article
  13. 13

    817. Caspofungin versus Anidulafungin in Patients with Candidemia: Retrospective Comparative Study by Elajez, Reem, Bakdach, Dana, Al Balushi, Sara, Abdallah, Tasneem, Zaqout, Ahmed, Alattar, Rand, Awouda, Waleed, Wilson, Godwin, Alsoub, Hussam Abdelrahman

    Published in Open forum infectious diseases (27-11-2023)
    “…Abstract Background Echinocandins are recommended as initial treatment for candidemia. The safety and efficacy of both anidulafungin and caspofungin are well…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Labeling of penicillin allergy in patients admitted to a tertiary hospital in Qatar: A retrospective audit by Hasan Elajez, Reem, Bakdach, Dana, Al-Adawi, Rana, Elgaily, Dina, Karawia, Ahmed, Mohamed, Asmaa

    Published in Qatar medical journal (20-06-2022)
    “…Background: Penicillin (PNC) allergy is a major healthcare concern that necessitates antibiotic substitution which is associated with increased costs, worse…”
    Get full text
    Journal Article
  16. 16

    Retrospective review of medication allergy labeling among patients admitted to a tertiary hospital in Qatar by Al-Adawi, Rana M., Elajez, Reem, Bakdach, Dana, Elgaily, Dina, Karawia, Ahmed, Mohamed, Asmaa

    Published in Qatar medical journal (31-05-2023)
    “…Background: Timely access to accurate, up-todate drug allergy information is critical to avoid potentially life-threatening adverse drug reactions (ADRs)…”
    Get full text
    Journal Article
  17. 17

    1242. Efficacy and Safety of Intravenous Fosfomycin for the Treatment of Multi-resistant Gram Negative Infections by Abdallah, Tasneem, Elajez, Reem, Ibrahim, Tawheeda, Alimam, Abeir, Omrani, Ali S

    Published in Open forum infectious diseases (04-12-2021)
    “…Abstract Background To describe the clinical use, efficacy and safety of intravenous (IV) fosfomycin in the treatment of infections caused by Gram-negative…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Efficacy and safety of once daily liraglutide versus twice daily exenatide in type 2 diabetic patients in Qatar: an observational study by Jassim, Zainab, Elajez, Reem, Khudair, Imran, Al Anany, Rasha, Al‐Adawi, Rana Moustafa

    “…Objective Compare efficacy and safety of liraglutide (1.8 mg subcutaneous once daily) and exenatide (10 mcg subcutaneous twice daily) in uncontrolled type 2…”
    Get full text
    Journal Article